Preda, Adrian
23 papers on CoChatORCID 0000-0003-3373-2438
Most cited papers
- Verified
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 1,202
- Verified
The genetic architecture of the human cerebral cortex
Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., Ching, C. R. K., McMahon, M. A. B., et al. (2020) · Science
Genetic Associations and EpidemiologyCognitive Abilities and Testing
Cited by 876
- Verified
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA schizophrenia DTI working group
Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., Andreassen, O. A., Arango, C., Banaj, N., Bouix, S., et al. (2018) · Molecular Psychiatry
Schizophrenia research and treatmentAdvanced Neuroimaging Techniques and Applications
Cited by 701
- Verified
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and Stage inference
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 596
- Verified
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., et al. (2006) · American Journal of Psychiatry
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 556
- Verified
Predicting alzheimer’s disease progression using multi-modal deep learning approach
Lee, G., Nho, K., Kang, B., Sohn, K.-A., Kim, D., Initiative, F. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2019) · Scientific Reports
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 406
- Verified
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Palmqvist, S., Zetterberg, H., Mattsson, N., Johansson, P., Initiative, F. T. A. D. N., Minthon, L., Blennow, K., Olsson, M., For the Swedish BioFINDER study group, Hansson, O., et al. (2015) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 375
- Verified
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease
Wolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 248
- Verified
Subregional neuroanatomical change as a biomarker for Alzheimer's disease
Holland, D., Brewer, J. B., Hagler, D. J., Fennema-Notestine, C., Dale, A. M., Initiative, T. A. D. N., Weiner, M., Thal, L., Petersen, R., Jack, C. R., et al. (2009) · Proceedings of the National Academy of Sciences
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 210
- Verified
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Risacher, S. L., Anderson, W. H., Charil, A., Castelluccio, P. F., Shcherbinin, S., Saykin, A. J., Schwarz, A. J., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M. W., et al. (2017) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 163
- Verified
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 156
- Verified
Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 151
- Verified
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
Miller, T. J., Zipursky, R. B., Perkins, D., Addington, J., Woods, S. W., Hawkins, K. A., Hoffman, R., Preda, A., Epstein, I., Addington, D., et al. (2003) · Schizophrenia Research
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 150
- Verified
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
Caroli, A., Prestia, A., Galluzzi, S., Ferrari, C., van der Flier, W. M., Ossenkoppele, R., Van Berckel, B., Barkhof, F., Teunissen, C., Wall, A. E., et al. (2015) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 142
- Verified
APOE genotype and early β-amyloid accumulation in older adults without dementia
Lim, Y. Y., Mormino, E. C., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., et al. (2017) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 125
- Verified
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
Zhou, X., Chen, Y., Mok, K. Y., Kwok, T. C. Y., Mok, V. C. T., Guo, Q., Ip, F. C., Chen, Y., Mullapudi, N., Initiative, A. D. N., et al. (2019) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 120
- Verified
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Franzmeier, N., Rubinski, A., Neitzel, J., Ewers, M., (ADNI), T. A. D. N. I., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2019) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 109
- Verified
Multimodal Fusion With Reference: Searching for Joint Neuromarkers of Working Memory Deficits in Schizophrenia
Qi, S., Calhoun, V. D., van Erp, T. G. M., Bustillo, J., Damaraju, E., Turner, J. A., Du, Y., Yang, J., Chen, J., Yu, Q., et al. (2018) · IEEE Transactions on Medical Imaging
Functional Brain Connectivity StudiesTensor decomposition and applications
Cited by 99
- Verified
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Neitzel, J., Franzmeier, N., Rubinski, A., Dichgans, M., Brendel, M., (ADNI), A. D. N. I., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., et al. (2021) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 57
- Verified
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease
Huang, M., Yang, W., Feng, Q., Chen, W., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2017) · Scientific Reports
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 55
- Verified
Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker
Qi, S., Schumann, G., Bustillo, J., Turner, J. A., Jiang, R., Zhi, D., Fu, Z., Mayer, A. R., Vergara, V. M., Silva, R. F., et al. (2021) · Biological Psychiatry
Neural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior
Cited by 55
- Verified
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification
Hett, K., Ta, V.-T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., et al. (2019) · Scientific Reports
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 49
- Verified
Special Report: AI-Induced Psychosis: A New Frontier in Mental Health
Preda, A. (2025) · Psychiatric News
Artificial Intelligence in Healthcare and EducationSchizophrenia research and treatment
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free